Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alain Schreiber currently holds 3,779,287 shares of AVANIR PHARMACEUTICALS (AVNR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alain Schreiber has been a net seller of AVNR stock. They have purchased $13.7M and sold $23.0M worth of shares.
Alain Schreiber's most recent insider trade was on Mar 20, 2017, when they sold 51,883 shares at $82.10 per share.
Alain Schreiber serves as Executive at AVANIR PHARMACEUTICALS (AVNR). They have executed 136 insider transactions totaling $36.8M over their tenure at the company.
Alain Schreiber holds the position of Executive at AVANIR PHARMACEUTICALS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Alain Schreiber has shown a selling trading pattern, with $13.7M in total purchases and $23.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alain Schreiber was on Jul 18, 2008, when they purchased $5.3M worth of OPTR shares. This transaction involved 628,931 shares at $8.48 per share.
Alain Schreiber currently owns 3,779,287 shares of AVANIR PHARMACEUTICALS (AVNR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alain Schreiber's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alain Schreiber has 136 Form 4 filings on record as an insider at AVANIR PHARMACEUTICALS.
Set alerts for Alain Schreiber and 40,000+ other insiders.